A randomized trial of micronized progesterone for the prevention of recurrent preterm birth

American Journal of Perinatology

Volumn 28, Issue 5, 2011, Pages 377-381

  Glover, Melanie M ^a   McKenna, David S ^a,b   Downing, Cathy M ^a   Smith, Dana B ^a   Croom, Christopher S ^a   Sonek, Jiri D ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Berry Building ^*  (United States)

Author keywords

micronized; Preterm delivery; prevention; progesterone; recurrent

Indexed keywords

MICRONIZED PROGESTERONE; PLACEBO; PROGESTERONE; PROGESTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EVENING DOSAGE; FATIGUE; FEMALE; GESTATIONAL AGE; HUMAN; HYPNOSIS; MATERNAL SERUM; NAUSEA; PILOT STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT SPONTANEOUS PRETERM BIRTH; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; THIRD TRIMESTER PREGNANCY; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; PILOT PROJECTS; PREGNANCY; PREMATURE BIRTH; PROGESTERONE; PROGESTINS; RECURRENCE; YOUNG ADULT;

EID: 79955074078     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0031-1274509     Document Type: Article

References (11)

1. March of Dimes Foundation. United States, Preterm Birth, Distribution of gestational age categories: US, 2006. 2010 Available at www.marchofdimes.com/ peristats
2. Creasy R K. Preterm birth prevention: where are we? Am J Obstet Gynecol 1993 168 1223-1230 (Pubitemid 23122173)
3. Meis P J., Klebanoff M, Thom E et al, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003 348 2379-2385 (Pubitemid 36682816)
4. Spong C Y. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 2007 110 2 Pt 1 405-415 (Pubitemid 47356668)
5. Simhan H N., Caritis S N. Prevention of preterm delivery. N Engl J Med 2007 357 477-487
6. Murad F, Haynes J RC. Estrogens and Progestins. In: Goodman L S. Gilman A Rall T W. Murad F eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 7th ed. New York McGraw-Hill 1985 1412-1439
7. Schering-Plough research institute. FDA Product Information: Prometrium (Progesterone USP) 100 mg capsules. Solvay Pharmaceuticals Inc 1998
8. ACOG Committee on Practice Bulletins. Fetal Lung Maturity. ACOG Practice Bulletin No. 97. Obstetrics and Gynecology. 2008
9. Iams J D., Romero R. Preterm birth In: Gabbe S G. Niebyl J R. Simpson J L. eds. Obstetrics: Normal and Problem Pregnancies. 5th ed. Philadelphia Churchill Livingston 2007 668-712
10. Goldenberg R L., Iams J D., Mercer B M. et al, NICHD MFMU Network. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. Am J Public Health 1998 88 233-238 (Pubitemid 28134082)
11. Rai P, Rajaram S, Goel N, Ayalur Gopalakrishnan R, Agarwal R, Mehta S. Oral micronized progesterone for prevention of preterm birth. Int J Gynaecol Obstet 2009 104 40-43